Restylane ®, Refyne™, Defyne™, Kysse™, Silk, Contour and Lyft™
This family includes the original Restylane to reduce the appearance of general facial wrinkles and folds. All are specifically formulated to work with your skin’s natural hyaluronic acid content. With each product the manufacturor Galderma has specific applications in mind. All combined, over 40 million treatments have been administered worldwide!
2003 is the year of Restylane‘s introduction. I still has a special place. This filler holds it’s own among all its siblings and competitors that have come along since. It has unique properties which make it very versatile. That means that if we can only have one filler option, it may as well be Restylane® because it is a good performer just about everywhere on the face. Having said that, there are now better options for many applications. But in our opinion Restylane®still excels around the eyes such as in the tear-trough zone. It is a good choice for heavier smoker’s lines in mature skin as well.
Fight Signs of Facial Aging
Reveal a younger, natural-looking you
Restylane® is a clear gel formulation of hyaluronic acid. It acts like and integrates with your skin’s own naturally produced hyaluronic acid. We use Restylane® to add volume and fullness in order to correct moderate to severe facial wrinkles and folds. Examples are the lines that run from your nose to the corners of your mouth (nasolabial folds) and from the corners of your mouth toward the chin (marionette lines).
Which Restylane® is for you?
A complimentary consultation with Dr. Robben will address your concerns and review the procedure and possible side effects.
Refyne takes on a moderate lines and folds such as laugh lines. Defyne addresses deeper lines and folds (laugh-lines, marionettes, etc.). XpresHAn™ technology allows for maximum flexibilty which benefits areas of movement and expression.
Kysse is specifically formulated to render beautiful lips and for the correction of upper perioral rhytids (vertical lip- (‘smokers’) lines). Newer XpresHAn™ technology allows for an ideal balance between support and flexibility and longer lasting results.
Additionally, the FDA approved Restylane® and Restylane® Silk for lip enhancement in patients over the age of 21. Both are uniquely suited to give your lips fullness and definition. Silk is the smoothest. It works well for fine, “etched-in” lines around the mouth and on the face as well as vertical lip lines. These are the ones that cause your lip stick to “bleed”.
Finally, Restylane® Contour has just received approval from the U.S. Food and Drug Administration (FDA), and will soon be available for cheek augmentation and correction of mid-face and lateral cheek contour deficiencies in adults over the age of 21 to add desired volume and shape in the cheek area.
Restylane® Contour is especially flexible and moves with your expression dynamics for a very natural result what differentiates. This makes it stand out what’s already on the market.
The most commonly observed side effects are bruising, redness, swelling, pain, tenderness, and itching at the injection site.
Finally, Lyft (formerly known as Perlane) stands out for more robust structural support. It has approval for cheek augmentation and the correction of age-related midface contour and volume deficiencies, as well as the treatment of heavier wrinkles and folds, such as the nasolabial folds (smile lines). It is good to rejuvenate the back of the hands as well when there are volume loss or prominent veins.
this link takes you to a representative treatment example
IN THE NEWS
COVID-19 update. Delayed dermal filler inflammatory events very rarely occur with both hyaluronic acid and non-hyaluronic acid fillers. Evidence suggests these reactions can be immunologically triggered by viral and bacterial illness. And with vaccinations such as the influenza vaccine, as well as dental procedures. These rare adverse events are temporary and respond to treatments such as oral corticosteroids and hyaluronidase, and often resolve without treatment. Given currently available data, patients already treated with dermal fillers should not be discouraged or precluded from receiving vaccines of any kind. Similarly, patients who have had vaccines should not be precluded from receiving dermal fillers in the future. Specifically, with regard to the Moderna mRNA-1273 trial, there were a total of 3 reactions possibly related to dermal fillers out of 15,184 vaccine recipients. It is unknown how many subjects in the trial had previous treatment with dermal fillers.
Click here for more information and unretouched photographs of real patients treated with Restylane injectable gel.